| # | Drug | Count |
|---|---|---|
| 0 | FLURBIPROFEN | 5 |
| 1 | VALACYCLOVIR | 5 |
| 2 | VALACYCLOVIR HYDROCHLORIDE | 5 |
| 3 | ASPIRIN | 3 |
| 4 | ASPIRIN 325 MG | 3 |
| 5 | ASPIRIN 81 MG | 3 |
| 6 | SITAGLIPTIN | 3 |
| 7 | ADALIMUMAB | 2 |
| 8 | ATENOLOL | 2 |
| 9 | FUROSEMIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLURBIPROFEN | 5 | 0.0033 |
| 1 | NITROUS OXIDE | 1 | 0.0005 |
| 2 | ADALIMUMAB-AFZB | 1 | 0.0004 |
| 3 | LORLATINIB | 1 | 0.0001 |
| 4 | FOSCARBIDOPA/FOSLEVODOPA | 1 | 0.0001 |
| 5 | CIMETIDINE | 1 | 0.0001 |
| 6 | DESLORATADINE | 1 | 0.0001 |
| 7 | TAFAMIDIS | 1 | 0.0001 |
| 8 | VALACYCLOVIR HYDROCHLORIDE | 5 | 0.0001 |
| 9 | KETOCONAZOLE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nitrate Vasodilator [EPC] | 2 | 0.0000 |
| 1 | Hepatitis C Virus NS5A Inhibitor [EPC] | 1 | 0.0000 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |
| 3 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 5 | Antirheumatic Agent [EPC] | 2 | 0.0000 |
| 6 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Nucleoside Analog Antiviral [EPC] | 1 | 0.0000 |
| 8 | Prostaglandin Analog [EPC] | 1 | 0.0000 |
| 9 | beta-Adrenergic Blocker [EPC] | 3 | 0.0000 |